Malnutrition in Elderly Patients with Chronic Kidney Disease-The Role of Albuminuria
- PMID: 40566551
- PMCID: PMC12194310
- DOI: 10.3390/life15060898
Malnutrition in Elderly Patients with Chronic Kidney Disease-The Role of Albuminuria
Abstract
Background: The global population is rapidly aging, and an epidemic increase in chronic kidney disease (CKD) has been reported. As the presence of malnutrition in elderly CKD patients can pose serious health problems, the aim of our study was to identify, using different assessment tools, the relationship between nutrition with kidney function and albuminuria in elderly patients. Methods: The study included 793 hospitalized patients aged 65 years and older. A comprehensive assessment of nutritional status and renal involvement was performed, and the relationship between malnutrition and kidney issues was tested. Results: CKD was highly prevalent in our geriatric population, with 39.84% having CKD G3a-5. Malnutrition, determined according to the Mini Nutritional Assessment (MNA) score, was identified in 34.6% of patients. With an increase in albuminuria, we observed worse nutrition indicators: low serum albumin; lower body fat (p = 0.002) and visceral fat (p = 0.001), assessed via bioimpedance; and lower MNA (p = 0.04) and geriatric nutritional risk index (GNRI) (p = 0.002) scores. Elderly patients with CKD G3a-5 had lower HDL-cholesterol (p < 0.001), higher triglycerides (p < 0.001), lower albumin (p = 0.011), and a lower MNA score (p = 0.001). Conclusions: Malnutrition was found to be common and more severe with increased albuminuria and decreased eGFR. Our study sheds light on a novel relationship between malnutrition, albuminuria, and renal function in a geriatric population.
Keywords: Mini Nutritional Assessment; albuminuria; bioelectrical impedance analysis; chronic kidney disease; elderly; geriatric nutritional risk index; malnutrition.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




Similar articles
-
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210. Health Technol Assess. 2010. PMID: 20441712
-
Nutrition support in hospitalised adults at nutritional risk.Cochrane Database Syst Rev. 2017 May 19;5(5):CD011598. doi: 10.1002/14651858.CD011598.pub2. Cochrane Database Syst Rev. 2017. PMID: 28524930 Free PMC article.
-
Assessment of nutritional status in elderly hospitalised patients with Parkinson's Disease: validation of CONUT and GNRI.Parkinsonism Relat Disord. 2025 Aug;137:107890. doi: 10.1016/j.parkreldis.2025.107890. Epub 2025 Jun 4. Parkinsonism Relat Disord. 2025. PMID: 40513385
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007751. doi: 10.1002/14651858.CD007751.pub2. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2023 Jul 19;7:CD007751. doi: 10.1002/14651858.CD007751.pub3. PMID: 21975774 Updated.
Cited by
-
Malnutrition and Its Effect on Drug Pharmacokinetics: A Clinical Perspective.Clin Pharmacokinet. 2025 Aug 12. doi: 10.1007/s40262-025-01558-5. Online ahead of print. Clin Pharmacokinet. 2025. PMID: 40797120 Review.
References
-
- World Health Organization Ageing and Health. who.int 2024. [(accessed on 23 March 2025)]. Available online: https://www.who.int/news-room/fact-sheets/detail/ageing-and-health.
-
- Heerspink H.J.L., Greene T., Tighiouart H., Gansevoort R.T., Coresh J., Simon A.L., Chan T.M., Hou F.F., Locatelli F., Praga M., et al. Change in Albuminuria as A Surrogate Endpoint for Progression of Kidney Disease: A Meta-Analysis of Treatment Effects in Randomised Clinical Trials. Lancet Diabetes Endocrinol. 2019;7:128–139. doi: 10.1016/S2213-8587(18)30314-0. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous